ENDRA Life Sciences Inc. (NASDAQ:NDRA) tinted gains of +4.72% (+0.11 points) to US$2.45. The volume of 0.06 Million shares climbed down over an trading activity of 96.19 Million shares. EPS ratio determined by looking at last 12 month figures is -2.13. Over the same time span, the stock marked US$5.88 as its best level and the lowest price reached was US$1.55. The corporation has a market cap of US$9.68 Million.
ENDRA Life Sciences Inc. (NASDAQ:NDRA)’s earnings per share has been growing at a 0 percent rate over the past 5 year when average revenue increase was noted as 0 percent. The return on equity ratio or ROE stands at -129.4 percent while most common profitability ratio return on investment (ROI) was -87.3 percent. The company’s institutional ownership is monitored at 12.8 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 51.7 percent gross margin.
Benitec Biopharma Limited (NASDAQ:BNTC) is worth US$687.23 Million and has recently risen 4.69% to US$3.35. The latest exchange of 0.1 Million shares is below its average trading activity of 89.37 Million shares. The day began at US$0 but the price moved to US$0 at one point during the trading and finally capitulating to a session high of US$0. The stock tapped a 52-week high of US$4.9 while the mean 12-month price target for the shares is US$14.
Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 3.56, and a price to sales ratio of 193.09. For the past 5 years, the company’s revenue has grown 0%, while the company’s earnings per share has grown 0%. With an institutional ownership near 0.89%, it carries an earnings per share ratio of -0.8.